Interventional Pulmonology Market Report 2024 (Global Edition)

Global Interventional Pulmonology Market Report 2024 Market Size Split by Indication (Asthma, COPD, Lung Cancer, Tracheal and Bronchial Stenosis, Others), by Product (Bronchoscopes, Electromagnetic Na...

Interventional Pulmonology Market Report Description

We have various report editions of Interventional Pulmonology Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Interventional Pulmonology Market Insights Video

Competitive Landscape of the Interventional Pulmonology Market

The Interventional Pulmonology Market is highly competitive, with major players like Medtronic, Boston Scientific, and Olympus leading the field. These companies focus on advanced technologies such as endobronchial ultrasound and navigational bronchoscopy to enhance diagnostic and therapeutic capabilities. They compete on innovation, product quality, and technological advancements. Additionally, firms are expanding their portfolios through strategic partnerships, acquisitions, and continuous R&D to meet the growing demand for minimally invasive pulmonology solutions.

November 2022: Konica Minolta Healthcare Americas introduced the Sonimage MX1 Platinum, a new point-of-care ultrasound system designed to enhance imaging capabilities. (Source: https://healthcare.konicaminolta.us/ultrasound/sonimage-mx1-platinum-ultrasound-system#:~:text=The%20SONIMAGE%C2%AE%20MX1%20Platinum%20L18%2D4%20Is%20a%20broad,resolution%20for%20more%20precise%20diagnosis.) November 2022: Fujifilm Healthcare Americas Corporation unveiled the Scenaria View Focus Edition Computed Tomography (CT) system in the United States. This advanced scanner features the Cardio StillShot, a sophisticated Cardiac Motion Correction technology. (Source: https://www.fujifilm.com/us/en/news/SCENARIAViewFocusEdition) October 2022: GE Healthcare introduced its latest all-digital PET/CT platform, Omni Legend, aimed at improving operational efficiency. (Source: https://www.gehealthcare.com/about/newsroom/press-releases/ge-healthcare-introduces-omni-legend-a-first-of-its-kind-all-digital-petct-system-to?npclid=botnpclid)

Top Companies Market Share in Interventional Pulmonology Industry: (In no particular order of Rank)

• Medtronic plc
• Boston Scientific Corporation
• Johnson & Johnson (Ethicon)
• Olympus Corporation
• Cook Medical
• ConMed Corporation
• Pentax Medical
• Hoya Corporation (Endoscopy Division)
• Stryker Corporation
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Interventional Pulmonology Market

Which Region Dominates the Interventional Pulmonology Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. It accounted for around 40% of the global revenue due to the region's advanced healthcare infrastructure, high adoption of innovative technologies, and substantial healthcare investments. The region benefits from leading medical research institutions and a high prevalence of respiratory diseases, driving demand for advanced diagnostic and therapeutic solutions. Additionally, strong reimbursement policies and a high level of healthcare awareness among the population further contribute to the market's dominance in North America.

Which Region is Expanding at the Fastest CAGR?

The Asia Pacific region is growing at the fastest CAGR in the Interventional Pulmonology Market due to rapid economic development, increasing healthcare investments, and a rising prevalence of respiratory diseases. Expanding healthcare infrastructure and the adoption of advanced technologies are enhancing access to interventional pulmonology services. Additionally, the large and growing elderly population and increasing awareness about respiratory health contribute to the rapid growth in this region.

The current report Scope analyzes Interventional Pulmonology Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Interventional Pulmonology Market

According to Cognitive Market Research, the global Interventional Pulmonology market size was estimated at USD 3351.2 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 1340.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.9% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Interventional Pulmonology market with a market size of USD 1057.64 million in 2024 and is projected to grow at a CAGR of 7.7% during the forecast period. The nation's advanced healthcare infrastructure, high adoption of innovative technologies, and a strong focus on respiratory care is driving the Interventional Pulmonology market.
• The Canada Interventional Pulmonology market had a market share of USD 160.86 million in 2024 and is projected to grow at a CAGR of 8.7% during the forecast period. Canada's improving healthcare policies is driving the Interventional Pulmonology market.
• The Mexico Interventional Pulmonology market is projected to witness growth at a CAGR of 8.4% during the forecast period, with a market size of USD 121.98 million in 2024.

Europe Interventional Pulmonology Market

According to Cognitive Market Research, the global Interventional Pulmonology market size was estimated at USD 3351.2 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 1005.36 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2031.

• The United Kingdom Interventional Pulmonology market had a market share of USD 168.90 million in 2024 and is projected to grow at a CAGR of 9.0% during the forecast period. In the UK, Interventional Pulmonology sales witness an upswing due to robust healthcare infrastructure, high prevalence of respiratory disorders, and increasing adoption of minimally invasive procedures.
• The France Interventional Pulmonology market is projected to witness growth at a CAGR of 7.4% during the forecast period, with a market size of USD 92.49 million in 2024.
• According to Cognitive Market Research, the German Interventional Pulmonology market size was valued at USD 199.06 million in 2024 and is projected to grow at a CAGR of 8.4% during the forecast period. In Germany, Interventional Pulmonology surged due to the presence of major market players.
• The Italy Interventional Pulmonology market is projected to witness growth at a CAGR of 7.6% during the forecast period, with a market size of USD 86.46 million in 2024.
• The Russia Interventional Pulmonology market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 155.83 million in 2024.
• The Spain Interventional Pulmonology market is projected to witness growth at a CAGR of 7.3% during the forecast period with a market size of USD 82.44 million in 2024
• The Luxembourg Interventional Pulmonology market is projected to witness growth at a CAGR of 8.3% during the forecast period, with a market size of USD 31.17 million in 2024.
• The Portugal Interventional Pulmonology market is projected to witness growth at a CAGR of 8.0% during the forecast period, with a market size of USD 21.11 million in 2024.
• The Greece Interventional Pulmonology market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 12.06 million in 2024.
• Rest of Europe's Interventional Pulmonology market is projected to witness growth at a CAGR of 6.9% during the forecast period, with a market size of USD 155.83 million in 2024.

Asia Pacific Interventional Pulmonology Market

According to Cognitive Market Research, the global Interventional Pulmonology market size was estimated at USD 3351.2 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 770.78 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.7% from 2024 to 2031.

• According to Cognitive Market Research, the China Interventional Pulmonology market size was valued at USD 346.85 million in 2024 and is projected to grow at a CAGR of 11.2% during the forecast period. Interventional Pulmonology surged in China due to rising prevalence of respiratory diseases, increasing healthcare expenditure, and expanding access to advanced medical technologies.
• The Japan Interventional Pulmonology market is projected to witness growth at a CAGR of 10.2% during the forecast period, with a market size of USD 106.37 million in 2024.
• The India Interventional Pulmonology market had a market share of USD 92.49 million in 2024 and is projected to grow at a CAGR of 13.5% during the forecast period. Increasing government initiatives to enhance healthcare services is driving the Interventional Pulmonology market.
• The South Korean Interventional Pulmonology market is projected to witness growth at a CAGR of 10.8% during the forecast period, with a market size of USD 77.08 million in 2024.
• The Australian Interventional Pulmonology market is projected to witness growth at a CAGR of 11.4% during the forecast period, with a market size of USD 40.08 million in 2024.
• The South East Asia Interventional Pulmonology market is projected to witness growth at a CAGR of 12.7% during the forecast period, with a market size of USD 53.18 million in 2024.
• The Rest of Asia Pacific Interventional Pulmonology market is projected to witness growth at a CAGR of 11.5% during the forecast period, with a market size of USD 54.73 million in 2024.

South America Interventional Pulmonology Market

According to Cognitive Market Research, the global Interventional Pulmonology market size was estimated at USD 3351.2 Million, out of which the Latin America market has more than 5% share of the global revenue with a market size of USD 167.56 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.1% from 2024 to 2031. .

• According to Cognitive Market Research, the Brazil Interventional Pulmonology market size was valued at USD 71.72 million in 2024 and is projected to grow at a CAGR of 9.7% during the forecast period. Interventional Pulmonologys flourished in Brazil due to increasing awareness of respiratory diseases, improved access to healthcare, and rising adoption of advanced medical technologies.
• Argentina's Interventional Pulmonology market had a market share of USD 28.15 million in 2024 and is projected to grow at a CAGR of 10.0% during the forecast period. Argentina's expansion of medical infrastructure augment the demand.
• Colombia Interventional Pulmonology market is projected to witness growth at a CAGR of 8.9% during the forecast period, with a market size of USD 14.91 million in 2024.
• Peru Interventional Pulmonology market is projected to witness growth at a CAGR of 9.3% during the forecast period, with a market size of USD 13.74 million in 2024.
• Chile Interventional Pulmonology market is projected to witness growth at a CAGR of 9.4% during the forecast period, with a market size of USD 12.06 million in 2024.
• The Rest of Latin America's Interventional Pulmonology market is projected to witness growth at a CAGR of 8.2% during the forecast period, with a market size of USD 26.98 million in 2024.

Middle East and Africa Interventional Pulmonology Market

According to Cognitive Market Research, the global Interventional Pulmonology market size was estimated at USD 3351.2 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 67.02 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.4% from 2024 to 2031..

• The GCC Countries Interventional Pulmonology market is projected to witness growth at a CAGR of 10.2% during the forecast period, with a market size of USD 28.69 million in 2024. Interventional Pulmonology sales flourish due to the presence of major market players.
• The Egypt Interventional Pulmonology market is projected to witness growth at a CAGR of 9.7% during the forecast period, with a market size of USD 7.04 million in 2024.
• The South Africa Interventional Pulmonology market is projected to witness growth at a CAGR of 10.4% during the forecast period, with a market size of USD 10.59 million in 2024. Interventional Pulmonology sales flourish in South Africa due to increasing investments in healthcare infrastructure, rising prevalence of respiratory diseases, and growing adoption of advanced medical technologies.
• The Turkey Interventional Pulmonology market is projected to witness growth at a CAGR of 8.9% during the forecast period, with a market size of USD 5.76 million in 2024.
• The Nigeria Interventional Pulmonology market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 7.04 million in 2024.
• The Rest of MEA Interventional Pulmonology market is projected to witness growth at a CAGR of 8.4% during the forecast period, with a market size of USD 7.91 million in 2024.

Interventional Pulmonology Market Analysis

Interventional Pulmonology Market Indication Segment Analysis

According to Cognitive Market Research, Asthma stands out as the dominant category. Asthma indication captures the largest market share in the Interventional Pulmonology Market due to the high prevalence of asthma globally, leading to increased demand for advanced diagnostic and therapeutic interventions. Asthma management often requires sophisticated procedures to monitor and treat airway inflammation and obstruction effectively. The focus on improving patient outcomes through innovative technologies and treatments drives significant market share for asthma-related interventions, reflecting the substantial need for effective solutions in managing this common respiratory condition.

COPD indication is growing at the highest CAGR in the Interventional Pulmonology Market due to the rising prevalence of chronic obstructive pulmonary disease, driven by factors such as smoking, air pollution, and aging populations. Increased awareness and early diagnosis are leading to higher demand for advanced interventional treatments to manage COPD symptoms and complications effectively. Additionally, advancements in technologies and therapies designed to improve respiratory function and quality of life for COPD patients are fueling this rapid market growth.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Interventional Pulmonology Industry. Request a Free Sample PDF!

Interventional Pulmonology Market Product Segment Analysis

According to Cognitive Market Research, the dominant category is Bronchoscopes. Bronchoscopes capture the largest market share in the Interventional Pulmonology Market due to their critical role in diagnosing and managing respiratory conditions. They are essential for procedures such as biopsy, airway inspection, and foreign body removal. The technology's versatility, accuracy, and the ability to perform minimally invasive procedures contribute to its widespread adoption. As demand for precise and efficient diagnostic tools increases, bronchoscopes remain a cornerstone in interventional pulmonology.

The Electromagnetic Navigation Bronchoscopy System is growing at the highest CAGR in the Interventional Pulmonology Market due to its advanced capabilities in precisely locating and targeting lung lesions. This technology enhances the accuracy of biopsy procedures and reduces procedural risks, leading to better patient outcomes. Its growing adoption is driven by increasing demand for minimally invasive techniques and advancements in imaging technologies, which improve diagnostic precision and overall efficiency in interventional pulmonology.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Interventional Pulmonology End-user Segment Analysis

Interventional Pulmonology Market End-user Segment Analysis

According to Cognitive Market Research, the dominant category is Hospitals. Hospitals capture the largest market share in the Interventional Pulmonology Market due to their comprehensive facilities and resources for performing complex diagnostic and therapeutic procedures. They are equipped with advanced technologies and specialized staff to handle a wide range of pulmonology cases, including severe and urgent conditions. Hospitals also benefit from higher patient volumes and integrated care services, which drive the demand for advanced interventional pulmonology equipment and contribute to their dominant market share.

Ambulatory Surgical Centers (ASCs) are growing at the highest CAGR in the Interventional Pulmonology Market due to their focus on providing cost-effective, outpatient procedures with reduced hospital stay times. The trend towards minimally invasive procedures and increasing patient preference for outpatient care are driving growth. ASCs benefit from lower operational costs and shorter recovery times, which make them attractive for both patients and healthcare providers, leading to a rapid increase in their market share.

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers
• Specialty Clinics
• Others

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion